Long-Term Cardiac Outcome in High-Risk Patients Undergoing Elective Endovascular or Open Infrarenal Abdominal Aortic Aneurysm Repair

European Journal of Vascular and Endovascular Surgery

Volumn 36, Issue 6, 2008, Pages 646-652

  Schouten, O ^a   Lever, T M ^b   Welten, G M J M ^a   Winkel, T A ^a   Dols, L F C ^a   Bax, J J ^c   van Domburg, R T ^a   Verhagen, H J M ^a,b   Poldermans, D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Abdominal aortic aneurysm; Endovascular; High cardiac risk; Medical therapy; Open

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; ENDOVASCULAR SURGERY; FEMALE; HEART STRESS; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

AGED; ANGIOPLASTY; AORTIC ANEURYSM, ABDOMINAL; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; MALE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 56049117152     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2008.09.008     Document Type: Article

References (24)

1. Blankensteijn J.D., de Jong S.E., Prinssen M., van der Ham A.C., Buth J., van Sterkenburg S.M., et al. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med 352 23 (2005) 2398-2405
2. Greenhalgh R.M., Brown L.C., Kwong G.P., Powell J.T., and Thompson S.G. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet 364 9437 (2004) 843-848
3. Lederle F.A. Abdominal aortic aneurysm-open versus endovascular repair. N Engl J Med 351 16 (2004) 1677-1679
4. Kertai M.D., Boersma E., Bax J.J., Heijenbrok-Kal M.H., Hunink M.G., L'Talien G.J., et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 89 11 (2003) 1327-1334
5. Schouten O., Dunkelgrun M., Feringa H.H., Kok N.F., Vidakovic R., Bax J.J., et al. Myocardial damage in high-risk patients undergoing elective endovascular or open infrarenal abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 33 5 (2007) 544-549
6. Poldermans D., Fioretti P.M., Forster T., Thomson I.R., Boersma E., el-Said E.M., et al. Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation 87 5 (1993) 1506-1512
7. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 3 (2000) 959-969
8. Back M.R., Leo F., Cuthbertson D., Johnson B.L., Shamesmd M.L., and Bandyk D.F. Long-term survival after vascular surgery: specific influence of cardiac factors and implications for preoperative evaluation. J Vasc Surg 40 4 (2004) 752-760
9. Hertzer N.R., Beven E.G., Young J.R., O'Hara P.J., Ruschhaupt III W.F., Graor R.A., et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 199 2 (1984) 223-233
10. Boersma E., Poldermans D., Bax J.J., Steyerberg E.W., Thomson I.R., Banga J.D., et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 285 14 (2001) 1865-1873
11. Welten G.M., Schouten O., Hoeks S.E., Chonchol M., Vidakovic R., van Domburg R.T., et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol 51 16 (2008) 1588-1596
12. Schouten O., Bax J.J., Dunkelgrun M., Feringa H.H., van Urk H., and Poldermans D. Statins for the prevention of perioperative cardiovascular complications in vascular surgery. J Vasc Surg 44 2 (2006) 419-424
13. Kertai M.D., Boersma E., Westerhout C.M., Klein J., Van Urk H., Bax J.J., et al. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 28 4 (2004) 343-352
14. Durazzo A.E., Machado F.S., Ikeoka D.T., De Bernoche C., Monachini M.C., Puech-Leao P., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39 5 (2004) 967-975 [discussion 975-976]
15. Kertai M.D., Boersma E., Westerhout C.M., van Domburg R., Klein J., Bax J.J., et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 116 2 (2004) 96-103
16. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G., et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33 Suppl. 1 (2007) S1-S75
17. Poldermans D., Boersma E., Bax J.J., Thomson I.R., van de Ven L.L., Blankensteijn J.D., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch echocardiographic cardiac risk evaluation applying stress echocardiography study group. N Engl J Med 341 24 (1999) 1789-1794
18. Poldermans D., Boersma E., Bax J.J., Thomson I.R., Paelinck B., van de Ven L.L., et al. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 22 15 (2001) 1353-1358
19. Kertai M.D., Boersma E., Bax J.J., Thomson I.R., Cramer M.J., van de Ven L.L., et al. Optimizing long-term cardiac management after major vascular surgery: role of beta-blocker therapy, clinical characteristics, and dobutamine stress echocardiography to optimize long-term cardiac management after major vascular surgery. Arch Intern Med 163 18 (2003) 2230-2235
20. Devereaux P.J., Yang H., Yusuf S., Guyatt G., Leslie K., Villar J.C., et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371 9627 (2008) 1839-1847
21. Fleisher L.A., and Poldermans D. Perioperative beta blockade: where do we go from here?. Lancet 371 9627 (2008) 1813-1814
22. Poldermans D., Bax J.J., Schouten O., Neskovic A.N., Paelinck B., Rocci G., et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?. J Am Coll Cardiol 48 5 (2006) 964-969
23. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. Lancet 365 9478 (2005) 2187-2192
24. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet 365 9478 (2005) 2179-2186